Compare TXG & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TXG | PATH |
|---|---|---|
| Founded | 2012 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Prepackaged Software |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.6B | 5.6B |
| IPO Year | 2019 | 2021 |
| Metric | TXG | PATH |
|---|---|---|
| Price | $48.21 | $12.75 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 15 | 17 |
| Target Price | ★ $20.25 | $14.41 |
| AVG Volume (30 Days) | 2.8M | ★ 82.2M |
| Earning Date | 05-07-2026 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 76.97 | ★ 500.00 |
| EPS | N/A | ★ 0.04 |
| Revenue | $245,893,000.00 | ★ $1,610,572,000.00 |
| Revenue This Year | N/A | $11.82 |
| Revenue Next Year | $7.33 | $8.50 |
| P/E Ratio | ★ N/A | $308.88 |
| Revenue Growth | ★ 68.06 | 12.65 |
| 52 Week Low | $11.17 | $9.20 |
| 52 Week High | $49.84 | $19.84 |
| Indicator | TXG | PATH |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 61.13 |
| Support Level | $16.11 | $12.36 |
| Resistance Level | N/A | $12.83 |
| Average True Range (ATR) | 2.89 | 0.78 |
| MACD | -0.23 | 0.08 |
| Stochastic Oscillator | 60.79 | 89.70 |
10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives operates from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).
UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies, including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries, including claims processing, employee onboarding, invoice-to-cash, loan applications, and customer service. The company works in the Americas, Europe, the Middle East, and Africa, and Asia-Pacific, with the maximum revenue from the America.